MicroRNA-219c-5p regulates bladder fibrosis by targeting FN1

Bowen Liu1,2, Yafei Ding1, Peng Li1

  • 1Department of Urology, Zhengzhou University First Affiliated Hospital, Zhengzhou, 450052, China.

BMC Urology
|December 8, 2020
PubMed
Abstract

Insights

Fibronectin 1 (FN1) is upregulated in fibrotic bladders, while miR-219c-5p is downregulated. MiR-219c-5p directly targets FN1, inhibiting bladder fibrosis and offering a potential therapeutic target.

Area of Science:

  • Urology
  • Molecular Biology
  • Fibrosis Research

Background:

  • Bladders of multiple sclerosis mice exhibit significant fibrosis.
  • Fibronectin 1 (FN1) is implicated in bladder fibrosis development.
  • MicroRNAs (miRNAs) are investigated for their role in regulating FN1.

Purpose of the Study:

  • To investigate the relationship between FN1 and bladder fibrosis.
  • To identify microRNAs regulating FN1 expression in bladder fibrosis.
  • To explore the therapeutic potential of miR-219c-5p in bladder fibrosis.

Main Methods:

  • Immunohistochemistry to assess bladder fibrosis.
  • RT-qPCR and Western blotting for FN1 expression analysis.
  • Bioinformatics, cell-based assays (luciferase, CCK8, cell cycle, apoptosis), and in vivo transfection (agomir/anagomir) to study miR-219c-5p and FN1 interaction and effects.

Main Results:

  • Increased bladder fibrosis correlated with higher FN1 and lower miR-219c-5p expression.
  • miR-219c-5p directly targets and inhibits FN1 synthesis.
  • miR-219c-5p overexpression reduced bladder smooth muscle cell proliferation and promoted apoptosis; knockdown had opposite effects.
  • In vivo administration of miR-219c-5p agomir reduced bladder fibrosis in mice.

Conclusions:

  • FN1 upregulation and miR-219c-5p downregulation are key in bladder fibrosis progression.
  • miR-219c-5p exerts antifibrotic effects by regulating FN1.
  • miR-219c-5p represents a potential diagnostic and therapeutic target for bladder fibrosis.